Here is What Institutional Investors Think About China Jo-jo Drugstores Inc

China Jo-Jo Drugstores, Inc. is a retailer and distributor of pharmaceutical and other healthcare products found in a retail pharmacy in the People’s Republic of China. The company has a market cap of $29.26 million. The Company’s operating divisions include retail drugstores, online pharmacy, wholesale business selling products similar to those the Company carries in its pharmacies, and farming and selling herbs used for traditional Chinese medicine . It has 33.31 P/E ratio. The Firm has 59 store locations under the store brand Jiuzhou Grand Pharmacy in Hangzhou.

It is up 28.82% since August 11, 2015 and is downtrending. It has underperformed by 26.09% the S&P500.

Analysts await China Jo-Jo Drugstores Inc to reports earnings on July, 4.

According to Zacks Investment Research, “China Jo-Jo Drugstores, Inc., through its contractually controlled affiliates, operates a retail pharmacy chain in China offering both western and traditional Chinese medicine. Its contractually controlled affiliates include Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd., Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine General Partnership, and Hangzhou Jiuzhou Medical & Public Health Service Co., Ltd. The chain has stores throughout Hangzhou, the provincial capital of Zhejiang Province.”

Sabby Management Llc holds 0.05% of its portfolio in China Jo-Jo Drugstores Inc for 614,149 shares. California Public Employees Retirement System owns 29,300 shares or 0% of their US portfolio. Moreover, Morgan Stanley has 0% invested in the company for 34,787 shares. The New York-based Renaissance Technologies Llc has invested 0% in the stock. Sabal Trust Co, a Florida-based fund reported 12,400 shares.